Connect with us

General News

Can Marijuana Treat Depressive Disorders?

Published

on

 

Medical marijuana is getting the same popularity as a magic pill, if not more. With a little research, scientists have collected a lot of evidence on the wonders it can do including mental health problems.

According to a study last year, people who used marijuana reported to have fewer symptoms of depression. Smoking marijuana alleviates signs of anxiety and depressive attacks within a short time. However, the effect does not work in the long run, and the symptoms appear again. This study appears online in the Journal of Affective Disorders.

Scientists from Washington State University in Pullman conducted this study. They examined data from around 12000 people through a mobile application. The application enables medical marijuana consumers to keep track of apparent symptoms before the substance use. They can also note down the outcomes in the form of signs after cannabis use. This way, they can compare the two results, and the researchers used the comparison for their study.

There is little research on the effects of marijuana on depressive disorders. Most of the research is linking with the properties of the active compound tetrahydrocannabinol which is present in the substance. According to scientists from the study, the subjects under interest did not consume the product in lab premises. It was instead an observational study that allowed the users to consume the product in their comfort zone instead of a laboratory.

Marijuana with the adjusted ratio is helpful in managing the symptoms

Marijuana with a ratio adjusted according to higher cannabidiol (CBD) and low tetrahydrocannabinol (THC) was efficient in reducing depression-related symptoms. However, the long term effects turned out to be perplexing. They found that the signs in the long term aggravated.

In the case of anxiety, there was no fixed ratio required as in depression to alleviate the symptoms. Ten puffs were enough to lower the levels of stress in the users.

An important factor to acknowledge is the importance of both active compounds in easing the symptoms. CBD and THD both are equally significant in treating depressive disorder if the ratio is correct.

Gender wise, women encountered lesser symptoms of anxiety and depression in using marijuana in comparison to men. All these results point towards the fact that proper awareness and guidance to people is the need of the hour so that they can benefit from the substance.

medical marijuana for depression

Marijuana can also alleviate symptoms of chronic stress

There has been another research in 2015 in the University of Buffalo’s Research Institute on Addictions. The scientists examined that endocannabinoids are associated with better moods in people. These are chemicals present in the brain and activate the same receptors as tetrahydrocannabinol.

On rodent testing, the scientists concluded that endocannabinoids are not produced in sufficient quantities in people suffering from chronic stress. THC could fill up the scarcity and hence could be used as a substitute for the chemical. Not only that, it might help normalize the chemical function and reduce depressive disorder symptoms.

Are the effects only short term?

A little evidence is present to prove that cannabis can be used as an antidepressant. However, there are some significant loopholes in this evidence. According to a phenomenon Amotivational Syndrome, people who consume marijuana lose empathic skills. Moreover, they tend to isolate themselves and have a lesser than average capability to carry out daily activities.

So even though marijuana shortly treats the apparent signs of depressive disorders, it lacks the tendency to provide a permanent cure. Also, scientists suggest adopting to vaping as it is less harmful than smoking.

There is a dire need for all organizations and researching bodies to sit on a table and have an extended framework for research. With more states legalizing the medical marijuana laws and decriminalizing possession, there is a hope that scientists will dive deeper into looking multi dimensionally into the problem. This way they will be able to find ways to improvise the potential of the substance for the treatment of depression.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

Luxembourg: The First European Country To Legalize Marijuana

Published

on

Europe Marijuana legalization

Many of the states of the USA have legalized recreational and medicinal marijuana, but in Europe, the laws are strict. Medicinal cannabis is limitedly legal. But Luxembourg will soon become the first country to decriminalize cannabis.

On Friday, the government of Luxembourg announced via a statement that it is legal to grow and use cannabis. As per the new legislation, individuals above 18 in the county will have permission to consume marijuana. Moreover, they can grow four cannabis plants.

One household can cultivate only four plants. With the new law in action, the county would become the only county that permits the production and use of the drug without any limitations.

What Changes Can Occur By Altering The Legislation Regarding Marijuana

Cannabis will become available. Its manufacturing, development, sale, and consumption will no longer be illegal. The decriminalization of marijuana will drastically reduce the rate of the current fine.

Currently, any person possessing three grams of cannabis can be subject to a pay fine between $29 and $581. Previously, individuals were to pay for drug possession, and amerce can vary from $291 to $2910.

ALSO READ: VisiShield Review – How To Know It Is A Safe Choice?

The legislation of Luxembourg does permit marijuana use and cultivation but publically using the drug is still illegal. The new law allows the trading of cannabis seeds. Moreover, there are no limitations on the concentration or quantity of THC in the seeds undergoing the trading process. Tetrahydrocannabinol is the psychoactive compound of weed that can make people high.

The change in the law regarding marijuana will enable the government to clear out cannabis relating drug crimes. Another aim of making the alterations in legislation is to clamp down the drugs trade in the black market. Under the new law, Ministers will be regulating the currently illegal marijuana market.

The new cannabis policy has the support of the government. But to make it official, a vote of parliament is essential. After the voting of parliament in favor, the new proposal will get confirmation.

Chances Of Relaxation In Cannabis Law Across Europe 

Luxembourg is a beautiful county with political and communal stability. People are close to their culture, and it is the best place to do business. It has the highest living standards that make it worth living.

It has a population of over 600,000 individuals and is the first to move on the forefront in decriminalizing marijuana. Overall the European continent is moving towards relaxation of cannabis laws.

In a referendum in 2022, Italy will decide about its stand on the legalization of cannabis. Whether Italy will decriminalize pot or not depends upon the number of people in favor. Once the campaign groups become able to gather 500000 required signatures to force a vote, marijuana will become legal.

So far, Italian law permits the consumption of cannabis. Thus, no fine or punishment is inflicted upon its use. Usage of medical cannabis is also legal under the law of Italy. But, purchasing, selling, and cultivating weed on a large scale is against the legislation. Drug dealers can end up in prison for ten years if found guilty.

All the actions that can lead to imprisonment under current Italian law will become legal. But only when the people vote to legalize marijuana in the referendum. After the majority voted in favor, the sale, purchase, and cultivation of cannabis will become legal.

ALSO READ: Cannabis Oil Effectively Reduces Chronic Pain

Other European countries are also considering changing their laws about the use, sale, purchase, cultivation, manufacturing, and distribution of marijuana. Rules and regulations regarding cannabis involving activities are likely to change in the near two to three years.

Also Covered on: CNN

Continue Reading

Cannabis

NY Cannabis Board Permits Residential Medical Marijuana Production 

Published

on

Cannabis New York

The cannabis legalization and decriminalization bill are in practice in NY, rules for medical marijuana are set. The Cannabis Board is responsible for resolving matters involving medical and recreational weed. We are working efficiently to design regulations and procedures. The firm is determined to ensure cannabis-involved activities operate lawfully within the state.

The New York Cannabis board on Thursday issued rules to allow medical marijuana users to cultivate or produce these plants at home. Caregivers also have permission to grow medical hemp plants for their use at their residence.

NY Cannabis Board Proposal

A final decision regarding the cultivation of medical marijuana is yet to occur. Doing so will enable individuals to become self-sufficient in medical cannabis. According to the proposal of the board, they can grow several plants for personal use at home.

ALSO READ: Luxembourg: The First County To Legalize Marijuana

For now, the proposal is open for discussion to the public, and people can comment on it for a period of sixty days. The proposal permits the growth of up to six medical marijuana plants in residential space. After the closing of the commentary period of 60 days, the regulation will take effect. By the end of this period, the cannabis board will finalize the ordinance in its official language.

Since 2014, medical marijuana, despite being legal, was not available in the market. It was also not easy to access items that consisted of constituents of the cannabis plant.

Previous practice

People used to visit medical dispensaries and facilities to purchase cannabis for their treatment. These items are usually expensive, and there is no insurance policy that can help in paying the expenses on sales of cannabis. According to an observational finding, people purchase products from Vireo Health Company. According to the company, a patient, usually on the first visit to a nearby dispensary, spends between $100 and $350.

Residential medical marijuana growth will facilitate many patients and make it easy for them to access cannabis. Once the regulation becomes official, individuals can cultivate six plants in their private living area.

The state Senator Diane Savino also passed remarks on the rules and regulations regarding medical marijuana. According to Daine Savino, the NY Cannabis board proposes the best policy. Diane appreciates Governor Kathy Hochul and the entire team of the board in addressing the issue of medical pot.

According to Diane, the matter regarding cannabis issuance for caregivers and certified patients has been long-standing. Fortunately, the board members address the topic swiftly.

The Road To Medical Marijuana Cultivation At Residents 

In NY, recreational pot legislation approval occurred in March 2021. The Marijuana Regulation and Taxation Act was also approved. The decision by the Cannabis Board to legalize medical marijuana production is the first step to putting the Act in action.

The Act does give permission to cultivate pot for medical reasons once the Board puts rules and regulations in place. According to the previous decision, the board members were to provide practical policy within six months of recreational legalization. However, Governor Andrew Cuomo neglected to appoint the board members, so the deadline passed.

Things move forward in a better way after Hochul takes control of the office and assembles it. After taking office in August, till the present, two meetings have already occurred. The Board discusses and implements rules regarding medical marijuana and recreational cannabis legalization.

According to Tremaine Wright, due to the quick action of governor Hochul and lawmakers, the medical pot program will soon expand. The expansion will lead to many other benefits and help in building a new industry. These activities will help in operating the medical marijuana industry safely. The Cannabis Control Board chair, in a statement, highlights the importance of medical pot regulations.

Originally covered on: Gothamist

Continue Reading

Cannabis

Cannabis Oil Effectively Reduces Chronic Pain

Published

on

The use of cannabis oil and other medical items containing marijuana legal since 2018 in the UK. However, the evidence of marijuana being efficacious has come under light recently. Researchers are discovering the effectiveness of marijuana oil in chronic pain patients.

Multiple studies occurred to determine the effectiveness of cannabis oil. Patients receiving marijuana as part of their treatment feel much better and experience improvement in their health.

Gathering Evidence Of Cannabis Oil Being Effective For Chronic Pain Patients

The United Kingdom Medical Cannabis Registry enrolls one hundred and ten patients. The purpose of enrolling these patients was to observe the effectiveness of cannabis oil. Moreover, through these patients, the impact of marijuana on overall improving quality of life was determined.

ALSO READ: New York Cannabis Board Relaxes Medical Cannabis Rules

The registry reports that enrolled patients feel much better after one, three, and six months of cannabis oil intake. They experience that their pain reduces after using medical pot. They experience comfort, and their sleep quality has improved hugely. According to the registry, there are significant improvements in patients’ health-associated quality of life.

The National Health Service of the United Kingdom has a strict cannabis oil prescription policy. It is hard for patients to get a marijuana prescription because of the strict rules of the NHS. Patients who don’t respond well to conventional therapy have access to medical marijuana. The conditions under which patients can access medical marijuana include pain sufferers, individuals with anxiety issues, and multiple sclerosis.

About sixty-five percent of the patients part of the study had never used cannabis oil or medical marijuana. The participants are primarily diagnosed with chronic non-cancer pain, neuropathic pain, and fibromyalgia.

16% of the participants suffered from fibromyalgia and 48% percent from chronic non-cancer pain. Twenty-four percent of the participants are suffering from neuropathic pain.

Experts Focus On Research

For the betterment of society and its safety, it is vital to gather research-based evidence. Doctors and scientists consider it essential to discover the realities of using cannabis before prescribing it.

Dr. Simon Erridge is the head of research at Sapphire Medical Clinics. In a statement, he said that the number of medical marijuana prescriptions is increasing quickly in the UK. In this situation, it is essential to determine the outcomes of patients. Collecting real-world practical evidence regarding cannabis oil consumption is vital.

According to Dr. Simon, this research that they conducted is one of a kind in Europe. His team will continuously review inpatients, outpatients, and marijuana products via the Medical Cannabis Registry UK. So far, the selection of observational data has occurred. In the future, more critical research, including randomized controlled investigations, will occur.

Sapphire Medical Clinics developed the registry. They survey patients suffering from various diseases receiving separate prescriptions depending upon their condition. Surveying these individuals enables us to reduce the knowledge gap.

Filling the blank space regarding medical marijuana and cannabis oil in scientific knowledge helps a lot. The study’s findings were published in the well-known scientific journal, the Journal of Clinical Pharmacology.

The research does prove that medical marijuana is effective in improving multiple conditions of people. But researchers require more research to form guidelines, funders, and licensing agencies.

Adven is a subsidiary of Curaleaf International. It is one of the largest independent marijuana companies in Europe. Adven cannabis oil was used in studies such that the average CBD dose was 20mg per day. The average THC dose that participants get is 1mg per day. Administration of cannabis oil occurs in a ratio CBD/THC of 20 to 1.

More participants enrolled in the survey process. Sapphire Medical Clinic plans to continue its survey-based research.

Continue Reading

Trending

error: Content is protected !!